IO Biotech ApS

https://www.iobiotech.com

LinkedIn: https://www.linkedin.com/company/io-biotech

IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology platform. The T-win® platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. IO Biotech is advancing in clinical studies its lead immuno-oncology candidate, IO102-IO103, targeting IDO and PD-L1, and through clinical and preclinical development its other pipeline candidates. IO Biotech is headquartered in Copenhagen, Denmark. *

	Start	2014-12-01 splitoff
	Group	IO Biotech (Group)
	Industry	cancer vaccine

	Region	København (Copenhagen)
	Country	Denmark
	Street	3 Ole Maaløes Vej COBIS
	City	2200 København N
	Tel	+45-21-947856
		Address record changed: 2021-11-26

Basic data	Employees	B: 11 to 50 (2021-12-31)
	Currency	USD
	Profit	-67,879,000 (2021-12-31)
	Cash	211,531,000 (2021-12-31)

		* Document for »About Section«: IO Biotech, Inc.. (11/9/21). "Press Release: IO Biotech, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares". Wilmington, DE.

		Record changed: 2024-04-17

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for IO Biotech (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)